ciprofloxacin has been researched along with Enteritis in 18 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Enteritis: Inflammation of any segment of the SMALL INTESTINE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated the use of azithromycin (500 mg) or ciprofloxacin (500 mg) daily for 3 days for the treatment of acute diarrhea among United States military personnel in Thailand." | 9.08 | Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. ( Amato, S; Echeverria, P; Hoge, CW; Kuschner, RA; Olafson, RP; Pitarangsi, C; Sadoff, JC; Taylor, DN; Thomas, RJ; Trofa, AF, 1995) |
| "The role of ciprofloxacin and trimethoprim-sulfamethoxazole (TMP-SMZ) was evaluated in empiric treatment of uncomplicated Salmonella enteritis in a comparative, double-blind trial." | 9.07 | Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trial. ( Bella, F; Cobo, E; Espejo, E; Freixas, N; Garau, J; García-Restoy, E; Lite, J; Sánchez, C; Sánchez, P; Simó, M, 1993) |
| "Cases of salmonella brain abscesses are reviewed." | 5.30 | Brain abscess caused by Salmonella enteritidis in an immunocompetent adult patient: successful treatment with cefotaxime and ciprofloxacin. ( Bonvin, P; Dons-Jensen, H; Ejlertsen, T, 1998) |
| "We evaluated the use of azithromycin (500 mg) or ciprofloxacin (500 mg) daily for 3 days for the treatment of acute diarrhea among United States military personnel in Thailand." | 5.08 | Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. ( Amato, S; Echeverria, P; Hoge, CW; Kuschner, RA; Olafson, RP; Pitarangsi, C; Sadoff, JC; Taylor, DN; Thomas, RJ; Trofa, AF, 1995) |
| "The role of ciprofloxacin and trimethoprim-sulfamethoxazole (TMP-SMZ) was evaluated in empiric treatment of uncomplicated Salmonella enteritis in a comparative, double-blind trial." | 5.07 | Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trial. ( Bella, F; Cobo, E; Espejo, E; Freixas, N; Garau, J; García-Restoy, E; Lite, J; Sánchez, C; Sánchez, P; Simó, M, 1993) |
| " There was no Campylobacter isolate resistant to erythromycin, which is recommended as a first-choice antimicrobial for humans when Campylobacter enteritis is strongly suspected." | 4.31 | [Prevalence and Characteristics of Campylobacter and Salmonella in Meat Derived from Spent Hens]. ( Momose, Y; Sasaki, Y; Uema, M; Yonemitsu, K, 2023) |
| "Ciprofloxacin is a new 4-quinolone antibacterial agent with an extended antibacterial spectrum, enhanced potency and the ability to produce therapeutic serum, tissue and urine concentrations after oral administration." | 2.37 | Overview of clinical experience with ciprofloxacin. ( Ball, AP, 1986) |
| "Campylobacter infections are typically self-limited, but in cases with severe enteritis, immuno-compromised system and bacteremia, an appropriate antimicrobial treatment is demanding." | 1.51 | Antimicrobial Susceptibility of Campylobacter isolates in the Capital of North Macedonia. ( Blazevska, A; Kostovski, M; Mihajlov, K; Mirchevska, G; Stojkovska, S; Trajkovska-Dokic, E, 2019) |
| "Cases of salmonella brain abscesses are reviewed." | 1.30 | Brain abscess caused by Salmonella enteritidis in an immunocompetent adult patient: successful treatment with cefotaxime and ciprofloxacin. ( Bonvin, P; Dons-Jensen, H; Ejlertsen, T, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (16.67) | 18.7374 |
| 1990's | 9 (50.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Sasaki, Y | 2 |
| Ikeda, T | 1 |
| Yonemitsu, K | 2 |
| Kuroda, M | 1 |
| Ogawa, M | 1 |
| Sakata, R | 1 |
| Uema, M | 2 |
| Momose, Y | 2 |
| Ohya, K | 1 |
| Watanabe, M | 1 |
| Hara-Kudo, Y | 1 |
| Okamura, M | 1 |
| Asai, T | 1 |
| Trajkovska-Dokic, E | 1 |
| Mihajlov, K | 1 |
| Mirchevska, G | 1 |
| Kostovski, M | 1 |
| Blazevska, A | 1 |
| Stojkovska, S | 1 |
| Ellström, P | 1 |
| Feodoroff, B | 1 |
| Hänninen, ML | 1 |
| Rautelin, H | 1 |
| Sieper, J | 1 |
| Braun, J | 1 |
| Reda, E | 1 |
| Mansell, C | 1 |
| Goodman, LJ | 1 |
| Fliegelman, RM | 1 |
| Trenholme, GM | 1 |
| Kaplan, RL | 1 |
| Sánchez, C | 1 |
| García-Restoy, E | 1 |
| Garau, J | 1 |
| Bella, F | 1 |
| Freixas, N | 1 |
| Simó, M | 1 |
| Lite, J | 1 |
| Sánchez, P | 1 |
| Espejo, E | 1 |
| Cobo, E | 1 |
| Kuschner, RA | 1 |
| Trofa, AF | 1 |
| Thomas, RJ | 1 |
| Hoge, CW | 1 |
| Pitarangsi, C | 1 |
| Amato, S | 1 |
| Olafson, RP | 1 |
| Echeverria, P | 1 |
| Sadoff, JC | 1 |
| Taylor, DN | 1 |
| Tee, W | 1 |
| Mijch, A | 1 |
| Wright, E | 1 |
| Yung, A | 1 |
| Gaunt, PN | 1 |
| Piddock, LJ | 1 |
| Williams, A | 1 |
| Bonvin, P | 1 |
| Ejlertsen, T | 1 |
| Dons-Jensen, H | 1 |
| Hof, H | 1 |
| Levine, J | 1 |
| Schmidt, MH | 1 |
| Burrell, MI | 1 |
| Hopkins, MS | 1 |
| Rao, RG | 1 |
| Ball, AP | 1 |
| Imagawa, Y | 1 |
| Tomizawa, I | 1 |
| Takizawa, Y | 1 |
| Ito, K | 1 |
| Matsubara, Y | 1 |
| Seo, T | 1 |
| Sagara, H | 1 |
| Tagawa, K | 1 |
| Masuda, G | 1 |
| Negishi, M | 1 |
2 reviews available for ciprofloxacin and Enteritis
| Article | Year |
|---|---|
[Diagnosis and antibiotic treatment of reactive arthritis].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Arthritis, Reactive; A | 2002 |
Overview of clinical experience with ciprofloxacin.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Enteritis; Enterob | 1986 |
3 trials available for ciprofloxacin and Enteritis
| Article | Year |
|---|---|
Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trial.
Topics: Acute Disease; Adult; Ciprofloxacin; Double-Blind Method; Drug Combinations; Enteritis; Feces; Femal | 1993 |
Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Campylobacter; Campylobacter Infe | 1995 |
[Comparison of clinical efficacy of ciprofloxacin (CPFX, BAY o 9867) and pipemidic acid (PPA) in the treatment of infectious enteritis by a double-blind method. The Japan Research Committee of Ciprofloxacin, Research Group for Infectious Enteritis].
Topics: Adolescent; Adult; Aged; Ciprofloxacin; Clinical Trials as Topic; Double-Blind Method; Dysentery, Ba | 1988 |
13 other studies available for ciprofloxacin and Enteritis
| Article | Year |
|---|---|
Antimicrobial resistance profiles of Campylobacter jejuni and Salmonella spp. isolated from enteritis patients in Japan.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter Infections; Campylo | 2023 |
[Prevalence and Characteristics of Campylobacter and Salmonella in Meat Derived from Spent Hens].
Topics: Animals; Campylobacter; Chickens; Ciprofloxacin; Enteritis; Erythromycin; Female; Humans; Meat; Prev | 2023 |
Antimicrobial Susceptibility of Campylobacter isolates in the Capital of North Macedonia.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter; | 2019 |
Characterization of clinical Campylobacter jejuni isolates with special emphasis on lipooligosaccharide locus class, putative virulence factors and host response.
Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Cell Line; Ciprofloxacin; Dox | 2013 |
Myocarditis in a patient with Campylobacter infection.
Topics: Adult; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Chest Pain; Ciprofloxa | 2005 |
Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens.
Topics: Anti-Bacterial Agents; Campylobacter; Ciprofloxacin; Enteritis; Humans; Microbial Sensitivity Tests; | 1984 |
Emergence of multidrug resistance in Campylobacter jejuni isolates from three patients infected with human immunodeficiency virus.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Campylob | 1995 |
Ciprofloxacin resistant Campylobacter spp. in humans: an epidemiological and laboratory study.
Topics: Adult; Animals; Anti-Infective Agents; Campylobacter; Case-Control Studies; Ciprofloxacin; Drug Resi | 1996 |
First the chicken, then the egg; the heartburn came later.
Topics: Adult; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Diagnos | 1997 |
Brain abscess caused by Salmonella enteritidis in an immunocompetent adult patient: successful treatment with cefotaxime and ciprofloxacin.
Topics: Adult; Anti-Infective Agents; Brain Abscess; Cefotaxime; Cephalosporins; Ciprofloxacin; Enteritis; H | 1998 |
[The therapy of Salmonella enteritis].
Topics: Ciprofloxacin; Enteritis; Humans; Lactulose; Salmonella Infections | 1992 |
Acute jejunoileitis. A distinct entity?
Topics: Adult; Barium Sulfate; Ciprofloxacin; Diagnosis, Differential; Enteritis; Erythromycin; Humans; Ilei | 1992 |
Development of spontaneous resistance to ciprofloxacin in a strain of Campylobacter jejuni.
Topics: Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Drug Resistance, Microbial; Enteritis | 1991 |